glp 1 hub podcast Vida’s VP of Clinical Strategy, @gretchenzimmermann.rd , recently joined the @glp1hub to talk about social determinants of health, obesity care, and the future of GLP-1s., From the cost Big changes may be coming

Patients with a family history of medullary thyroid carcinoma should discuss risks thoroughly with their healthcare provider before starting therapy

Like any powerful treatment, the decision to start, continue, pause, or stop should be made thoughtfully with your full health picture and long-term goals in view

This precision-medicine approach reduces trial-and-error adjustments and helps you sleep better while maximizing the benefits of your weight-loss therapy

A word on Conagras re-labeling strategy, which is the most conservative of the three: Healthy Choice was not originally a diet brand

More broadly, they challenge the traditional separation between metabolic and psychiatric disease, suggesting peripheral metabolic signals can influence central processes such as motivation and behavior